RESUMEN
Following of the emergence of Zika virus in Brazil in 2015, an epidemiological surveillance system was quickly implemented in the French overseas Territories of America (FTA) according to previous experience with dengue and chikungunya and has detected first cases of Zika. General practitioners and medical microbiologists were invited to report all clinically suspected cases of Zika, laboratory investigations were systematically conducted (RT-PCR). On 18 December, the first autochthonous case of Zika virus infection was confirmed by RT-PCR on French Guiana and Martinique, indicating introduction of Zika virus in FTA. The viral circulation of Zika virus was then also confirmed on Guadeloupe and Saint-Martin. We report here early findings on 203 confirmed cases of Zika virus infection identified by RT-PCR or seroneutralisation on Martinique Island between 24 November 2015 and 20 January 2016. All cases were investigated. Common clinical signs were observed (maculopapular rash, arthralgia, fever, myalgia and conjunctival hyperaemia) among these patients, but the rash, the foundation of our case definition, may be absent in a significant proportion of patients (16%). These results are important for the implementation of a suspected case definition, the main tool for epidemiological surveillance, in territories that may be affected by ZIKV emergence, including Europe.
Asunto(s)
Enfermedades Transmisibles Emergentes/epidemiología , Brotes de Enfermedades , Vigilancia de la Población , Infección por el Virus Zika/diagnóstico , Infección por el Virus Zika/epidemiología , Virus Zika/aislamiento & purificación , Humanos , Martinica/epidemiología , ARN Viral/genética , ARN Viral/aislamiento & purificación , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Análisis de Secuencia de ADN , Virus Zika/genética , Infección por el Virus Zika/transmisiónRESUMEN
To identify factors associated with disease severity, we examined 102 patients with quantitative PCR-confirmed leptospirosis in Martinique during 2010-2013. Associated factors were hypotension, chest auscultation abnormalities, icterus, oligo/anuria, thrombocytopenia, prothrombin time <68%, high levels of leptospiremia, and infection with L. interrogans serovar Icterohaemorrhagiae/Copenhageni.
Asunto(s)
Brotes de Enfermedades , Leptospirosis/epidemiología , Adulto , Animales , Enfermedades de los Perros/epidemiología , Enfermedades de los Perros/genética , Enfermedades de los Perros/patología , Perros , Femenino , Humanos , Leptospirosis/sangre , Leptospirosis/genética , Masculino , Martinica/epidemiología , Persona de Mediana Edad , Zoonosis/epidemiologíaAsunto(s)
Mielitis Transversa/virología , Infección por el Virus Zika/líquido cefalorraquídeo , Infección por el Virus Zika/diagnóstico , Adolescente , ADN Viral/genética , Femenino , Guadalupe , Humanos , Imagen por Resonancia Magnética , Reacción en Cadena en Tiempo Real de la Polimerasa , Virus Zika/genética , Virus Zika/aislamiento & purificaciónRESUMEN
OBJECTIVE: To characterize the full spectrum, relative frequency, and prognosis of the neurologic manifestations in Zika virus (ZIKV) postnatal infection. METHODS: We conducted an observational study in consecutive ZIKV-infected patients presenting with neurologic manifestations during the French West Indies 2016 outbreak. RESULTS: Eighty-seven patients, including 6 children, were enrolled. Ninety-five percent of all cases required hospitalization. Guillain-Barré syndrome was the most frequent manifestation (46.0%) followed by encephalitis or encephalomyelitis (20.7%), isolated single or multiple cranial nerve palsies (9.2%), other peripheral manifestations (6.9%), and stroke (1.1%). Fourteen patients (16.1%), including one child, developed a mixed disorder involving both the central and peripheral nervous system. Mechanical ventilation was required in 21 cases, all of whom had ZIKV RNA in at least one biological fluid. Two adult patients died due to neuroZika. Clinical follow-up (median 14 months; interquartile range, 13-17 months) was available for 76 patients. Residual disability (modified Rankin Scale score ≥2) was identified in 19 (25.0%) patients; in 6 cases (7.9%), disability was severe (modified Rankin Scale score ≥4). Among patients with ZIKV RNA detected in one biological fluid, the risk of residual disability or death was higher (odds ratio 9.19; confidence interval 1.12-75.22; p = 0.039). CONCLUSIONS: NeuroZika spectrum represents a heterogeneous group of clinical neurologic manifestations. During an outbreak, clinicians should consider neuroZika in patients presenting with cranial nerve palsies and a mixed neurologic disorder. Long-term sequelae are frequent in NeuroZika. ZIKV reverse-transcription PCR status at admission can inform prognosis and should therefore be taken into consideration in the management of hospitalized patients.
Asunto(s)
Enfermedades de los Nervios Craneales/terapia , Encefalitis Viral/terapia , Encefalomielitis/terapia , Síndrome de Guillain-Barré/fisiopatología , Infección por el Virus Zika/terapia , Adolescente , Adulto , Anciano , Niño , Preescolar , Enfermedades de los Nervios Craneales/metabolismo , Enfermedades de los Nervios Craneales/fisiopatología , Encefalitis Viral/metabolismo , Encefalitis Viral/fisiopatología , Encefalomielitis/metabolismo , Encefalomielitis/fisiopatología , Femenino , Hospitalización , Humanos , Lactante , Masculino , Persona de Mediana Edad , Pronóstico , ARN Viral/sangre , ARN Viral/líquido cefalorraquídeo , ARN Viral/orina , Respiración Artificial , Resultado del Tratamiento , Indias Occidentales , Infección por el Virus Zika/metabolismo , Infección por el Virus Zika/fisiopatologíaRESUMEN
Viral infectious vasculitis is a cause of stroke in children. Zika virus infection is often asymptomatic. Neurological complications have however been reported: Guillain-Barré, ADEM, meningoencephalitis, myelitis, microcephaly in the fetus of infected mothers. We discuss the case of a child presenting acute infection with ZIKV that was associated with a stroke. A 10-months-old boy without medical history presented after 2days of fever and cutaneous rash, conjunctivitis on day 5, a right hemiparesis on day 6. Brain MRI found an ischemic stroke in the left superficial MCA territory with distal occlusion of left M1 portion of the MCA. Specific real-time reverse PCR detected Zika virus in serum. There are no known cases of cerebral infarction associated with Zika infection. However, cases of cerebral infarcts associated with dengue vasculitis have rarely been described. It has been recently showed that there is a tropism of the Zika virus for endothelial cells. This could be responsible for stroke, possibly particularly in young children.
Asunto(s)
Isquemia Encefálica/etiología , Accidente Cerebrovascular/etiología , Vasculitis/complicaciones , Infección por el Virus Zika/complicaciones , Encéfalo/diagnóstico por imagen , Isquemia Encefálica/diagnóstico por imagen , Isquemia Encefálica/terapia , Diagnóstico Diferencial , Humanos , Lactante , Masculino , Accidente Cerebrovascular/diagnóstico por imagen , Accidente Cerebrovascular/terapia , Vasculitis/diagnóstico por imagen , Vasculitis/terapia , Infección por el Virus Zika/diagnóstico por imagen , Infección por el Virus Zika/terapiaRESUMEN
We evaluated a one-step sandwich-format microplate enzyme immunoassay for detecting dengue virus NS1 antigen (Ag) in human serum by use of Platelia Dengue NS1 Ag kits (Bio-Rad Laboratories, Marnes La Coquette, France). We collected 299 serum samples from patients with dengue disease and 50 serum samples from patients not infected with dengue virus. For the 239 serum samples from patients with acute infections testing positive by reverse transcription-PCR and/or virus isolation for one of the four dengue virus serotypes, the sensitivity of the Platelia Dengue NS1 Ag kit was 88.7% (95% confidence interval, 84.0% to 92.4%). None of the serum samples from patients not infected with dengue virus tested positive with the Platelia Dengue NS1 Ag kit. A diagnostic strategy combining the Platelia Dengue NS1 Ag test for acute-phase sera and immunoglobulin M capture enzyme-linked immunosorbent assay for early-convalescent-phase sera increased sensitivity only from 88.7% to 91.9%. Thus, NS1 antigen detection with the Platelia Dengue NS1 Ag kit could be used for first-line testing for acute dengue virus infection in clinical diagnostic laboratories.